Expression of microRNAs in the Urine of Patients With Bladder Cancer

详细信息    查看全文

• 作者：Gang Wang¹ ; Eddie Shu-Yin Chan² ; Bonnie Ching-Ha Kwan¹ ; Philip Kam-Tao Li¹ ; Sidney Kam-Hung Yip² ; Cheuk-Chun Szeto¹ ; ^{ccszeto@cuhk.edu.hk} ; Chi-Fai Ng²
• 关键词：Biomarker ; Gene expression ; Inflammation ; MicroRNA ; Urinalysis
• 刊名：Clinical Genitourinary Cancer
• 出版年：2012
• 出版时间：June, 2012
• 年：2012
• 卷：10
• 期：2
• 页码：106-113
• 全文大小：434 K

文摘

Background

MicroRNAs (miRNA) have been implicated to play an important role in the pathogenesis of a variety of cancers. We studied the levels of miRNAs related to epithelial-mesenchymal transition (EMT) in the urine of patients with bladder cancer.

Method

The expression of the miR-200 family, miR-205, miR-192, miR-155, and miR-146a in the urine sediment and supernatant of 51 patients with bladder cancer and in 24 controls was determined by real-time quantitative polymerase chain reaction.

Results

Compared with controls, the patients with bladder cancer had a lower expression of the miR-200 family, miR-192, and miR-155 in the urinary sediment; lower expression of miR-192; and higher expression of miR-155 in the urinary supernatant. The expression of the miR-200 family, miR-205, and miR-192 in the urine sediment significantly correlated with urinary expression of EMT markers, including zinc finger E-box-binding homeobox 1, vimentin, transforming growth factor ¦Â1, and Ras homolog gene family, member A. Furthermore, the levels of miR-200c and miR-141 in the urine sediment became normalized after surgery.

Conclusion

We found that the urinary miR-200 family, miR-155, miR-192, and miR-205 levels are depressed in patients with bladder cancer. The level of these miRNA targets in urine has the potential to be developed as noninvasive markers for bladder cancer.